Atorvastatin Calcium
Product Images NDC 71610-170
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71610-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Bottle Label 10 mg (71610 0169 60)
Bottle Label 80 mg (71610 0170 45)
Aphena Pharma Solutions (TN)
Figure-01 (Figure 01)
Figure-02 (Figure 02)
Figure-03 (Figure 03)
This text describes a comparison of two cholesterol-lowering drugs, Horvastatin and Sorvastatin. The percentage of subjects who experienced E vert is not mentioned clearly. However, the drugs' impact on the subjects is given, where Horvastatin reduced the risk of major cardiovascular endpoints by 22%, with a hazard ratio of 0.78 (0.69-0.89) and a P-value of 0.0002, compared to Sorvastatin, which is given at a dose of 80mg. The time taken to reach a major cardiovascular endpoint was not specified.*
Chemical-structure (Chemical Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.